Selective distribution of protein kinase A regulatory subunit Rllα in rodent gliomas

Neuro-Oncology

Volumn 10, Issue 6, 2008, Pages 958-967

  Mucignat Caretta, Carla ^a   Cavaggioni, Andrea ^a   Redaelli, Marco ^a   Malatesta, Manuela ^b   Zancanaro, Carlo ^b   Caretta, Antonio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

cAMP; Diagnosis; Glioblastoma; Golgi; Protein kinase a

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IIALPHA; PACLITAXEL; VINBLASTINE; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN TISSUE; BRAIN TUMOR; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; DRUG DISTRIBUTION; EPENDYMA CELL; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN LOCALIZATION; RAT; RODENT; SECOND MESSENGER; TRANS GOLGI NETWORK; ANIMAL; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; ENZYMOLOGY; METABOLISM; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIIALPHA SUBUNIT; DIAGNOSIS, DIFFERENTIAL; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; RATS;

EID: 60549088307     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1215/15228517-2008-054     Document Type: Article

References (42)

1. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol (Berl). 2005;109:93-108.
2. Stork PJ, Schmitt JM. Crosstalk between cAMP and MAP kinase signalling in the regulation of cell proliferation. Trends Cell Biol. 2002;12:258-266.
3. Ferrari S. Protein kinases controlling the onset of mitosis. Cell Mol Life Sci. 2006;63:781-795.
4. Sato S, Sugimura T, Yoda K, Fujimura S. Morphological differentiation of cultured mouse glioblastoma cells induced by dibutyryl cyclic adenosine monophosphate. Cancer Res. 1975;35:2494-2499.
5. Moreno MJ, Ball M, Andrade MF, McDermid A, Stanimirovic DB. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)- differentiated glioblastoma cells. Glia. 2006;53:845-857.
6. Prasad KN, Cole WC, Yan XD, et al. Defects in cAMP-pathway may initiate carcinogenesis in dividing nerve cells: a review. Apoptosis. 2003;8:579-586.
7. Vossler MR, Yao H, York RD et al. cAMP activates MAP kinase and Elk 1 through a Braf and Rap1 dependent pathway. Cell. 1997;89:73-82.
8. Boulogne B, Habert R, Levacher C. Regulation of the proliferation of cocultured gonocytes and Sertoli cells by retinoids, triiodothyronine and intracellular signalling factors: differences between fetal and neonatal cells. Mol Rep Dev. 2003;65:194-203.
9. Sevetson BR, Kong X, Lawrence JC. Increasing cAMP attenuates activation of mitogen activated protein kinase. Proc Natl Acad Sci USA. 1993;90:10305-10309.
10. Chen J, Iyvengar R. Suppression of Ras-induced transformation of NIH 3T3 cells by activated Gas. Science. 1994;263:1278-1281.
11. Cadd G, McKnight GS. Distinct patterns of cAMP-dependent protein kinase gene expression in mouse brain. Neuron. 1989;3:71-79.
12. Donelson Smith F, Langeberg LK, Scott JD. The where's and when's of kinase anchoring. Trends Biochem Sci. 2006;31:316-323.
13. Bossis I, Stratakis CA. Minireview. PRKAR1A: normal and abnormal functions. Endocrinology. 2004;145:5452-5458.
14. Nadella KS, Kirschner LS. Disruption of protein kinase A regulation causes immortalization and dysregulation of D-type cyclins. Cancer Res. 2005;65:10307-10315.
15. Neary CL, Nesterova M, Cho YS, Becker KG, Cho-Chung YS. Protein kinase A isozyme switching: eliciting differential cAMP signalling and tumor reversion. Oncogene. 2004;23:8847-8856.
16. Tortora G, Ciardiello F. Protein kinase A as target for novel integrated strategies of cancer therapy. Ann N Y Acad Sci. 2002;968:139-147.
17. Cho-Chung YS, Nesterova M, Becker KG, et al. Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis: antisense, microarray, gene overexpression, and transcription factor decoy. Ann N Y Acad Sci. 2002;968:22-36.
18. Uren A, Toretsky JA. Pediatric malignancies provide unique cancer therapy targets. Curr Opin Pediatr. 2005;17:14-19.
19. Tysnes BB, Mahesparan R. Biological mechanisms of glioma invasion and potential therapeutic targets. J Neurooncol. 2001;53:129-147.
20. Chen TC, Hinton DR, Zidovetzki R, Hofman FM. Up-regulation of cAMP PKA pathway inhibits proliferation, induces differentiation and leads to apoptosis in malignant gliomas. Lab Invest. 1998;78:165-174.
21. Hoelzinger DB, Mariani L, Weis J, et al. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia. 2005;7:7-16.
22. Cho YS, Park YG, Lee YN, et al. Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Cα and RIIβ subunit overexpression. Proc Natl Acad Sci USA. 2000;97:835-840.
23. Mucignat-Caretta C, Caretta A. Regional variations in the localization of insoluble kinase A regulatory isoforms during rodent brain development. J Chem Neuroanat. 2004;27:201-212.
24. Mucignat-Caretta C, Caretta A. Clustered distribution of cAMP-dependent protein kinase regulatory isoform RIalpha during the development of the rat brain. J Comp Neurol. 2002;451:324-333.
25. Mucignat-Caretta C, Caretta A. Localization of Triton-insoluble cAMP-dependent kinase type RIbeta in rat and mouse brain. J Neuro-cytol. 2001;30:885-894.
26. Szatmari T, Lumniczky K, Desaknai S, et al. Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci. 2006;97:546-553.
27. Barth RF. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neuro-oncol. 1998;36:91-102.
28. Dai C, Holland EC. Glioma models. Biochim Biophys Acta. 2001;1551:M19-M27.
29. Baldelli B, Vecchio L, Bottone MG, Muzzonigro G, Biggiogera M, Malatesta M. The effect of the enkephalin DADLE on transcription does not depend on opioid receptors. Histochem Cell Biol. 2006;126:189-197.
30. Yang HY, Lieska N, Glick R, Shao D, Pappas GD. Expression of 300-kilodalton intermediate filament-associated protein distinguishes human glioma cells from normal astrocytes. Proc Natl Acad Sci USA. 1993;90:8534-8537.
31. Ljubimova JY, Fugita M, Khazenzon NM, et al. Association between laminin-8 and glial tumor grade, recurrence, and patient survival. Cancer. 2004;101:604-612.
32. Almqvist PM, Mah R, Lendahl U, Jacobsson B, Hendson G. Immunohistochemical detection of nestin in pediatric brain tumors. J His-tochem Cytochem. 2002;50:147-158.
33. McLendon RE, Wikstrand CJ, Matthews MR, Al-Baradei R, Bigner SH, Bigner DD. Glioma-associated antigen expression in oligodendroglial neoplasms. Tenascin and epidermal growth factor receptor. J His- tochem Cytochem. 2000;48:1103-1110.
34. Herold-Mende C, Mueller MM, Bonsanto MM, Schmitt HP, Kunze S, Steiner HH. Clinical impact and functional aspects of tenascin-C expression during glioma progression. Int J Cancer. 2002;98:362-369.
35. Schwartz JP, Costa E. Protein kinase translocation following β-adren- ergic receptor activation in C6 glioma cells. J Biol Chem. 1980;255:2943-2948.
36. Frattola L, Canal N, Ferrarese C, et al. Multiple forms of protein kinase from normal human brain and glioblastoma. Cancer Res. 1983;43:1321-1324.
37. Derby MC, Lieu ZZ, Brown D, Stoe JL, Goud B, Gleeson PA. The trans- Golgi network golgin, GCC185, is required for endosome-to-Golgi transport and maintenance of Golgi structure. Traffic. 2007;8:758-773.
38. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, Longo DL. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol. 1998;18:3509-3517.
39. Chu JJ, Chen KD, Lin YL, et al. Taxol induces concomitant hyperphos- phorylation and reorganization of vimentin intermediate filaments in 9L rat brain tumor cells. J Cell Biochem. 1998;68:472-483.
40. Jang IS, Juhnn YS. Adaptation of cAMP signaling system in SH- SY5Y neuroblastoma cells following expression of a constitutively active stimulatory G protein alpha, Q227L Gsalpha. Exp Mol Med. 2001;33:37-45.
41. Ichimura K, Ohgaki H, Kleihues P, Collins VP. Molecular pathogenesis of astrocytic tumours. J Neurooncol. 2004;70:137-160.
42. Quigley MR, Post C, Ehrlich G. Some speculation on the origin of glioblastoma. Neurosurg Rev. 2007;30:16-21.